Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) — Cash Flow Quality Index
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Cash Flow Quality Index of 18.14x as of June 2025. Operating cash flow of CN¥55.33 Million exceeds net income of CN¥3.05 Million, indicating high earnings quality where cash backs reported profits. Also explore Shanghai Fudan-Zhangjiang Bio-Pharmaceut assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow Quality Index (2010–2024)
Historical Cash Flow Quality Index for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Fudan-Zhangjiang Bio-Pharmaceut tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2010–2024)
Year-by-year earnings quality comparison for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.37x | CN¥-14.77 Million | CN¥39.43 Million | ▼ -157.3% |
| 2023 | 0.65x | CN¥71.02 Million | CN¥108.63 Million | ▼ -45.7% |
| 2022 | 1.20x | CN¥165.27 Million | CN¥137.27 Million | ▼ -4.9% |
| 2021 | 1.27x | CN¥268.90 Million | CN¥212.38 Million | ▲ +84.0% |
| 2020 | 0.69x | CN¥113.00 Million | CN¥164.26 Million | ▼ -41.9% |
| 2019 | 1.18x | CN¥269.23 Million | CN¥227.36 Million | ▼ -2.6% |
| 2018 | 1.22x | CN¥173.94 Million | CN¥143.07 Million | ▲ +100.7% |
| 2017 | 0.61x | CN¥42.71 Million | CN¥70.50 Million | ▼ -35.0% |
| 2016 | 0.93x | CN¥140.57 Million | CN¥150.84 Million | ▲ +41.3% |
| 2015 | 0.66x | CN¥96.30 Million | CN¥145.95 Million | ▼ -4.3% |
| 2014 | 0.69x | CN¥88.36 Million | CN¥128.10 Million | ▼ -23.7% |
| 2013 | 0.90x | CN¥89.44 Million | CN¥98.95 Million | ▼ -52.7% |
| 2012 | 1.91x | CN¥110.19 Million | CN¥57.70 Million | ▲ +44.9% |
| 2011 | 1.32x | CN¥49.59 Million | CN¥37.63 Million | ▲ +173.9% |
| 2010 | -1.78x | CN¥-7.11 Million | CN¥3.99 Million | — |